Kromasil preparative HPLC applications – success stories
1. Purification of insulin

Kromasil packing media are today the dominating materials used for large-scale production of human insulin and variants, among many other applications. Multi-ton volumes of Kromasil per year are used globally to produce these APIs, with high purity demands.
This article will show an example of the development work that has been performed to facilitate cost-effective processes for the final purification of human insulin, and to service our customers in order to lower their costs.

schematic illustration of insulin chains
Figure 1 - Schematic illustration of insulin

For human insulin (HI), two of the most demanding impurities to remove are A21 desamido HI, and B30 des-threonine HI. The A21 desamido HI is an impurity where the A21 asparagine is hydrolyzed to aspartic acid, and the B30 des-threonine HI is an impurity where the B30 threonine is missing.

Figure 1 shows the structure of insulin schematically, with the A and B chain being coupled together via disulfide bonds.

Analytical method for insulin purification
Figure 2 - Analytical method for insulin purification
  • Conditions

  • Sample purity: 90%
  • Column: Kromasil 100-3.5-C4 4.6 x 120 mm
  • Mobile phase: acetonitrile/50 mM sodium phosphate
  •  + 100 mM sodium perchlorate buffer, pH 2.5
  • Gradient: 0 min: 30%, 55 min: 36% acetonitrile
  • Flow rate: 1.0 ml/min
  • Detection: 214 nm

Figure 2 shows the analytical chromatogram of a crude insulin sample, where purity is 90%, and the two most demanding impurities are indicated.

Preparative insulin purification with impurity coelution
Figure 3 - Preparative insulin purification with impurity coelution
  • Conditions

  • 20 mg crude on a 4.6 x 250 mm column
  • Mobile phase: acetonitrile/ 0.2 M ammonium acetate buffer, pH 4
  • Gradient: 0 min: 22%, 60 min: 32% acetonitrile
  • Flow rate: 0.7 ml/min
Preparative insulin purification with impurity displacement
Figure 4 - Preparative insulin purification with impurity displacement
  • Conditions

  • 20 mg crude on a 4.6 x 250 mm column
  • Proprietary ion-pairing chromatography method

When using RP chromatography to purify polypeptides or small proteins such as insulin, typically a shallow gradient is used. The chromatogram in figure 3 shows a case where some standard conditions are applied for the purification of human insulin containing a relatively high amount of des-threonine HI. It can be seen that the human insulin and the main impurity more or less co-elute, giving no possibility to collect any significant yield of pure insulin.

However, if the standard conditions as seen in figure 3 are replaced by a mobile phase where an ion-pairing agent has been added to the mobile phase, a significant improvement of the chromatography can be obtained. The des-threonine HI is pushed out due to a strong positive displacement effect, and > 98% pure insulin can be collected, with about 80% yield.

The above example shows the extreme importance of performing an extensive method development work before deciding the chromatographic conditions for the large-scale production. If the purification is to be run for a long time, even small improvements in yield and purity can result in huge savings in separation cost.


Temporary message

If this message does not disappear by itself when the page is fully loaded; either a javascript error has occurred or javascript is disabled in your browser.